Relapsing Illness Due to Rochalimaea henselae in Immunocompetent Hosts: Implication for Therapy and New Epidemiological Associations

Daniel Lucey,* Matthew J. Dolan, C. Wayne Moss, Maria Garcia, Dannie G. Hollis, Scott Wegner, Greg Morgan, Roy Almeida, Diane Leong, Kay S. Greisen, David F. Welch, and Leonard N. Slater From the Departments of Medicine and Pathology, Wilford Hall U.S. Air Force Medical Center, Lackland Air Force Base, Texas; Analytical Chemistry Laboratory and Special Bacterial Reference Laboratory, Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, Center for Infectious Diseases, Centers for Disease Control, Atlanta, Georgia; Roche Molecular Systems, Alameda, California; and University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma